Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Chem Inf Model ; 59(9): 4007-4017, 2019 09 23.
Artigo em Inglês | MEDLINE | ID: mdl-31449404

RESUMO

Human type II topoisomerases (TopoII) are essential for controlling DNA topology within the cell. For this reason, there are a number of TopoII-targeted anticancer drugs that act by inducing DNA cleavage mediated by both TopoII isoforms (TopoIIα and TopoIIß) in cells. However, recent studies suggest that specific poisoning of TopoIIα may be a safer strategy for treating cancer. This is because poisoning of TopoIIß appears to be linked to the generation of secondary leukemia in patients. We recently reported that enzyme-mediated DNA cleavage complexes (in which TopoII is covalently linked to the cleaved DNA during catalysis) formed in the presence of the anticancer drug etoposide persisted approximately 3-fold longer with TopoIIα than TopoIIß. Notably, enhanced drug-target residence time may reduce the adverse effects of specific TopoIIα poisons. However, it is still not clear how to design drugs that are specific for the α isoform. In this study, we report the results of classical molecular dynamics (MD) simulations to comparatively analyze the molecular interactions formed within the TopoII/DNA/etoposide complex with both isoforms. We also used smoothed potential MD to estimate etoposide dissociation kinetics from the two isoform complexes. These extensive classical and enhanced sampling simulations revealed stabilizing interactions of etoposide with two serine residues (Ser763 and Ser800) in TopoIIα. These interactions are missing in TopoIIß, where both amino acids are alanine residues. This may explain the greater persistence of etoposide-stabilized cleavage complexes formed with Topo TopoIIα. These findings could be useful for the rational design of specific TopoIIα poisons.


Assuntos
Antineoplásicos/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Etoposídeo/metabolismo , Simulação de Dinâmica Molecular , Terapia de Alvo Molecular , Antineoplásicos/farmacologia , Domínio Catalítico , DNA Topoisomerases Tipo II/química , Etoposídeo/farmacologia , Humanos , Isoenzimas/química , Isoenzimas/metabolismo , Cinética
2.
Bioorg Med Chem Lett ; 28(17): 2961-2968, 2018 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-30006062

RESUMO

Etoposide is an anticancer drug that acts by inducing topoisomerase II-mediated DNA cleavage. Despite its wide use, etoposide is associated with some very serious side-effects including the development of treatment-related acute myelogenous leukemias. Etoposide targets both human topoisomerase IIα and IIß. However, the contributions of the two enzyme isoforms to the therapeutic vs. leukemogenic properties of the drug are unclear. In order to develop an etoposide-based drug with specificity for cancer cells that express an active polyamine transport system, the sugar moiety of the drug has been replaced with a polyamine tail. To analyze the effects of this substitution on the specificity of hybrid molecules toward the two enzyme isoforms, we analyzed the activity of a series of etoposide-polyamine hybrids toward human topoisomerase IIα and IIß. All of the compounds displayed an ability to induce enzyme-mediated DNA cleavage that was comparable to or higher than that of etoposide. Relative to the parent drug, the hybrid compounds displayed substantially higher activity toward topoisomerase IIß than IIα. Modeling studies suggest that the enhanced specificity may result from interactions with Gln778 in topoisomerase IIß. The corresponding residue in the α isoform is a methionine.


Assuntos
Etoposídeo/farmacologia , Proteínas de Ligação a Poli-ADP-Ribose/antagonistas & inibidores , Poliaminas/farmacologia , Inibidores da Topoisomerase II/farmacologia , DNA Topoisomerases Tipo II/metabolismo , Relação Dose-Resposta a Droga , Etoposídeo/síntese química , Etoposídeo/química , Humanos , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Ligantes , Simulação de Acoplamento Molecular , Estrutura Molecular , Proteínas de Ligação a Poli-ADP-Ribose/metabolismo , Poliaminas/química , Relação Estrutura-Atividade , Inibidores da Topoisomerase II/síntese química , Inibidores da Topoisomerase II/química
3.
Chemistry ; 22(1): 295-301, 2016 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-26584591

RESUMO

An artificial nucleoside surrogate with 1H-imidazo[4,5-f][1,10]phenanthroline (P) acting as an aglycone has been introduced into DNA oligonucleotide duplexes. This nucleoside surrogate can act as a bidentate ligand, and so is useful in the context of metal-mediated base pairs. Several duplexes involving a hetero base pair with an imidazole nucleoside have been investigated. The stability of DNA duplexes incorporating the respective Ag(I) -mediated base pairs strongly depends on the sequence context. Quantum mechanical/molecular mechanical (QM/MM) calculations have been performed in order to gain insight into the factors determining this sequence dependence. The results indicated that, in addition to the stabilizing effect that results from the formation of coordinative bonds, destabilizing effects may occur when the artificial base pair does not fit optimally into the surrounding B-DNA duplex.


Assuntos
DNA de Forma B/química , Imidazóis/química , Oligonucleotídeos/química , Compostos Organometálicos/química , Fenantrolinas/química , Prata/química , Pareamento de Bases , Dicroísmo Circular , Ligantes , Modelos Moleculares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...